CA-DNSC/DRUPA-2016
31.5.2016 15:09:45 CEST | Business Wire | Press release
Diversified Nano Solutions Corporation (DNSC) will be exhibiting digital INKS unlimited at Drupa “Touch the Future” 2016, May 31 – June 10, 2016, in Düsseldorf, Germany, at Halle 2-B05
Based in San Diego, California, with manufacturing facilities in the US and Europe, DNSC specializes in developing and manufacturing digital inks, nano materials, and fluids for high-resolution, high-performance digital inkjet printing. DNSC provides unique ink development services, research, and turn-key ink supply and fulfillment solutions reaching end users, resellers and, printer manufacturers worldwide. DNSC has developed an extensive product line under the x-nano™ brand, providing a range of solutions including high-quality, low-cost black & color dye inks (Value-Series), pigment inks (Elite Series), special ultra-fast dry inks (S-Series), magnetic MICR inks (K-Series), invisible fluorescent color (RGB) inks, infrared-absorbing inks (I-Series), and special inks for food grade, textile, and special effect applications (F-, T-, and X-Series). The company’s digital inks target dot-on-demand inkjet applications based on thermal and piezo print heads using aqueous, oil, energy-curable (UV/LED), and eco-solvent based inks.
DNSC offers a wide array of inkjet inks at unprecedented low cost supporting direct mail, transactional, transpromo, books, catalogs/magazines, ticket, tags, labels, and graphics printing applications. DNSC is uniquely positioned to help users create differentiated, high-value output through personalization using x-nano™ special effect inks such as magnetic (MICR), invisible fluorescent, spot color, and security inks for thermal & piezo digital inkjet platforms.
The company supports its ink offerings with accessories to facilitate and aid x-nano™ ink use and applications. These include specialty substrates, UV display lights, INKVERSE™ “Infinite Ink Infuser” – a revolutionary and cost-effective way to adopt and deliver digital inks to existing and new inkjet systems via a continuous delivery ink supply system, and TransChrome™ – an Invisible Color Image Generator to transform CMYK into UV fluorescent RGB output, and more.
At Drupa 2016, DNSC introduces X-Series, a new family of pigment powders and dispersions to serve as base components for custom development and production of ink, paint, paste, dispersion, gel, cream, and powder. These special effect base materials photo-luminesce, fluoresce, absorb IR, and change color with light or heat. X-Series materials have highly customizable properties that allow for various exceptionally unique market applications associated with digital and non-digital printing applications.
DNSC will be showcasing its line of black & color, magnetic, invisible, special effect, and security inks for the world’s leading inkjet print systems in the desktop, commercial, and industrial inkjet space.
Visit Halle 2-B05 and discover DNSC digital INKS unlimited!
View source version on businesswire.com: http://www.businesswire.com/news/home/20160531005263/en/
Contact:
Diversified Nano Solutions Corporation
Kimberly Villwock
US:
+1.858.924.1005
EU: +41.41 874 08 50
kimberlyv@diversifiednano.com
info@diversifiednano.com
www.diversifiednano.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetApp Completes Acquisition of PEAK:AIO to Accelerate Zettabyte-scale AI Deployments2.11.2026 14:00:00 CET | Press release
Acquisition strengthens NetApp Novus, high-performance storage, with differentiated metadata technology and a parallel file architecture purpose-built for AI NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that it completed the acquisition of PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. With this acquisition, NetApp can leverage metadata services and parallel namespace innovations to power the fastest storage on the planet, NetApp Novus, to support zettabyte-scale file systems for the most demanding workloads of AI clouds and GPU-as-a-service providers. For the best AI infrastructure economics, organizations need to keep GPU resources continuously supplied with data without bottlenecks. The acquisition advances NetApp’s strategy for the next phase of AI infrastructure by bringing PEAK:AIO’s metadata and parallel file system expertise together with NetApp ONTAP, giving customers a path to AI
Bentley Systems Announces Seequent’s Acquisition of Seismic Interpretation Software Company Eliis2.11.2026 14:00:00 CET | Press release
Strengthens Seequent’s subsurface software portfolio, energy and geophysics capabilities, and expands team of specialists Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that Seequent, The Bentley Subsurface Company, has acquired seismic interpretation software company Eliis. The acquisition will enrich Seequent’s capabilities in geophysics with seismic data interpretation and further advance subsurface understanding to help solve complex global challenges. Eliis’ global team of more than 100 geoscientists, technical specialists, and researchers will join Seequent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261029964674/en/ 3D view from PaleoScan showcasing recent advancements in seismic interpretation workflows that support prospect evaluation and exploration decision-making Founded in 2007 and with headquarters in Montpellier, France, Eliis develops advanced
HistoSonics Receives Regulatory Approval in Singapore, Advancing Expansion Across Asia-Pacific2.11.2026 14:00:00 CET | Press release
HistoSonics today announced that the company has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison® Histotripsy System (under the device name HistoSonics Histotripsy System), marking another significant milestone in the company’s continued international expansion and creating new opportunities to advance access to histotripsy throughout the Asia-Pacific region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102090757/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image-guided platform that uses the mechanical properties of focused ultrasound, known as histotripsy, to mechanically destroy and liquefy unwanted tissue and tumors. The technology offers a fundamentally new approach to tissue destruction without the need for invasive procedures, radiation, or thermal energy. The Edison System is currently authorized for the destruction of liver
NIQ Publishes 2026 ESG Progress Report, Highlighting Action Across Climate, People, Communities, and Responsible AI2.11.2026 12:45:00 CET | Press release
Report details NIQ’s continued focus on responsible business, including its first climate risk assessment, expanded employee development and more than 100,000 volunteer hours NIQ (NYSE: NIQ), a leading consumer intelligence company, today released its 2026 Environmental, Social and Governance (ESG) Progress Report, detailing the company’s progress on key ESG priorities throughout 2025. The report covers NIQ’s efforts across environmental responsibility, its people and communities, data integrity, and responsible AI. Key highlights from 2025 include:Strengthened its approach to climate risk and environmental measurement: NIQ conducted its first climate risk assessment aligned with Task Force on Climate-related Financial Disclosures (TCFD) recommendations, tracked Scope 1, 2 and 3 emissions under the GHG Protocol, and externally verified its carbon footprint. Invested in associate development, engagement and well-being: Internal mobility increased to 35%, up from 30%, while performance r
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer2.11.2026 12:42:00 CET | Press release
In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic response rate after one BOT dose and two BAL dosesNo patients treated with BOT+BAL had their cancer return, with median follow-up of 19.2 months in MSS disease and 16.7 months in MSI-H disease; 12-month event-free survival was 100% in both combination cohorts.Independent, multicenter UNICORN findings reinforce the NEST peer-reviewed neoadjuvant evidence supporting Agenus’ planned Phase 3 ROBBIN trial in curative-intent MSS/pMMR colon cancer Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter Phase 2 UNICORN trial evaluating short-course preoperative, or neoadjuvant, botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, alone or in combination with ba
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom